This test analyzes multiple genes associated with Primary Immunodeficiency Disorders using advanced Next-Generation Sequencing (NGS) on EDTA blood. Metropolis Healthcare performs this panel to detect hereditary defects that weaken the immune system and increase susceptibility to recurrent or severe infections. It provides valuable insights for accurate diagnosis and targeted clinical management. Early identification helps guide personalized treatment and family risk assessment.
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0243
Frequently Asked Questions (FAQ's):
What does the Primary Immunodeficiency Gene Panel include?
This panel at Metropolis Healthcare covers a wide range of genes linked to primary immune system disorders to identify disease-causing mutations.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses high-accuracy NGS sequencing to detect genetic variants that contribute to immune dysfunction.
Who should consider taking this test?
Individuals with frequent infections, poor response to treatment, unusual infection patterns, or suspected immune deficiencies should consider testing at Metropolis Healthcare.
Why is this genetic test important?
It helps confirm or rule out inherited immunodeficiency, enabling precise diagnosis and management through Metropolis Healthcare’s advanced genetic platform.
Is a blood sample required for this test?
Yes, Metropolis Healthcare conducts the test using an EDTA blood sample to obtain high-quality DNA.
Can this test support early diagnosis in children?
Yes, Metropolis Healthcare’s genetic testing is suitable for both children and adults showing signs of immune dysfunction.
How long does it take to receive the results?
Turnaround times may vary, but Metropolis Healthcare aims to deliver comprehensive genetic reports promptly.
Does this test help with family screening?
Yes, results from Metropolis Healthcare can guide family testing and genetic counseling for inherited risk